Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: October 29, 2020 12:09:08 am A healthcare worker takes a nasal swab sample at a COVID-19 testing center in Hyderabad (AP) With the results of late-stage clinical trials by two Covid-19 vaccine pioneers, Moderna Inc and Pfizer, …
Read More »
A COVID-19 vaccine may be available to some people before Christmas, said Kate Bingham, chair of the UK government’s vaccine task force in an interview. However, a launch in early 2021 is more likely, he added. “The first phase III efficacy data for the main vaccine candidates should be available …
Read More »
The wait for the Covid-19 vaccine may be longer for the young population in good health, said World Health Organization chief scientist Dr. Soumya Swaminathan at a WHO social media event. . “Most people agree, it’s starting with healthcare workers and front-line workers, but even there, you need to define …
Read More »
The Union Health Ministry has asked states to submit priority population lists that will receive the Covid-19 vaccine first by the end of October, Minister Harsh Vardhan said. The priority population refers to those who are at higher risk of contracting the virus than others. The government is working around …
Read More »
Amid growing concerns about the efficacy of Covid-19 vaccines in development, several participants in Moderna and Pfizer’s human trial program reported high fever, body aches, headaches, and exhaustion. However, these are common for any vaccine and are not a cause for alarm, experts have said. Here are the latest Covid-19 …
Read More »
In the ongoing race for an effective Covid-19 vaccine, several pharmaceutical companies are exploring out of the ordinary places. Johnson & Johnson is testing a single-shot vaccine, while traditional vaccine candidates require two injections. Bharat Biotech has announced the manufacture of an intranasal vaccine, which will differentiate it from intramuscular …
Read More »
Written by Prabha Raghavan, edited by Explained Desk | New Delhi | Updated: September 18, 2020 12:25:23 pm A new vaccine is on display at the Nikolai Gamaleya National Center for Epidemiology and Microbiology in Moscow, Russia. (AP) Pharmacist Dr. Reddy’s Laboratories (DRL) announced on Wednesday (September 16) that it …
Read More »
After pharmaceutical company AstraZeneca announced the resumption of its Covid-19 vaccine trial in the UK, its partner at India Serum Institute said it will also restart trials once the General Medicines Controller of India (DGCI) gives its okay. The DGCI previously sent a show of cause notice to the Pune-based …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: September 11, 2020 7:29:25 am Covid-19 testing in New Delhi. IBS Sponsors Mid- and Late-Stage Human Clinical Trials for Candidate Vaccine in India Serum Institute of India has decided to stop the ongoing clinical trials in India of the Covid-19 candidate …
Read More »
Written by Abhishek De | New Delhi | Updated: September 7, 2020 9:27:45 pm According to the World Health Organization, about 175 vaccine candidates are in preclinical or clinical trials today. While Russia and China may have stolen a march in the race to develop a Covid-19 vaccine, grant regulatory …
Read More »